Premium
PORTUGUESE REAL‐LIFE EXPERIENCE WITH IBRUTINIB OUTSIDE CLINICAL TRIALS – A MULTICENTER ANALYSIS
Author(s) -
Silva S.,
Espada E.,
Melo J.A.,
Lima M.P.,
Ionita A.,
Carda J.P.,
Andrade J.,
Neves M.,
Cabral R.,
Mendes T.,
Gaspar C.,
Alves D.,
Pina F.,
Botelho de Sousa A.,
Coelho H.,
Montalvão A.,
Vitória H.,
Lima F.,
Coutinho J.,
Lúcio P.,
Guimarães J.E.,
Ribeiro M.L.,
Gomes da Silva M.,
Raposo J.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_146
Subject(s) - ibrutinib , medicine , adverse effect , rituximab , chronic lymphocytic leukemia , clinical trial , fludarabine , ighv@ , oncology , leukemia , chemotherapy , cyclophosphamide , lymphoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom